USL255 extended‐release topiramate: Dose‐proportional pharmacokinetics and tolerability in healthy volunteers
Author:
Affiliation:
1. Upsher‐Smith Laboratories, Inc. Maple Grove Minnesota U.S.A
2. Center for Orphan Drug Research College of Pharmacy University of Minnesota Minneapolis MinnesotaU.S.A
Funder
Upsher-Smith Laboratories, Inc.,
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.12654
Reference33 articles.
1. Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
2. Extended-release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate-release formulations
3. Extended-Release Formulations of Antiepileptic Drugs: Rationale and Comparative Value
4. How Often Is Medication Taken as Prescribed?
5. Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study;Expert Opinion on Investigational Drugs;2024-06-03
2. Pharmacokinetics, pharmacodynamics, safety and tolerability of FTP-198, a novel, selective Autotaxin inhibitor, in healthy subjects: A phase I randomized placebo-controlled trial;European Journal of Pharmaceutical Sciences;2023-10
3. The pharmacokinetics of single oral dose extended‐release topiramate and adverse effects after multi‐dose administration in healthy cats;Journal of Veterinary Pharmacology and Therapeutics;2023-03-05
4. Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians;Epilepsy & Behavior;2021-07
5. Usefulness of extended‐release topiramate in patients with epilepsy: A two‐year retention study;Journal of Clinical Pharmacy and Therapeutics;2021-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3